ANXA9 as a novel prognostic biomarker associated with immune infiltrates in gastric cancer
Background Gastric cancer (GC) is the most prevalent malignancy among the digestive system tumors. Increasing evidence has revealed that lower mRNA expression of ANXA9 is associated with a poor prognosis in colorectal cancer. However, the role of ANXA9 in GC remains largely unknown. Material and Met...
Main Authors: | Tongtong Zhang, Suyang Yu, Shipeng Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2021-12-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/12605.pdf |
Similar Items
-
ANXA2 is a potential biomarker for cancer prognosis and immune infiltration: A systematic pan-cancer analysis
by: Yijie Ning, et al.
Published: (2023-01-01) -
ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma
by: Shuochen Liu, et al.
Published: (2023-05-01) -
TMEM200A is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer
by: Fujin Fang, et al.
Published: (2023-06-01) -
The macrophage-associated prognostic gene ANXA5 promotes immunotherapy resistance in gastric cancer through angiogenesis
by: Zhijun Hong, et al.
Published: (2024-01-01) -
ANXA1 is identified as a key gene associated with high risk and T cell infiltration in primary sclerosing cholangitis
by: Jian Zhang, et al.
Published: (2023-09-01)